Public procurement notice: Additional Information
Published: 2020-02-07
Buyer: The NHS Commissioning Board (Operating under the name of NHS England)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 85149000
Submission deadline: 2020-03-09
Award criteria: The most economic tender

Technical requirements: NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies - East of England, London and South East Coast
NHS Framework Agreement to supply Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies — East of England, London and South East Coast. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework agreement will commence on 1.7.2020 for a period of 12 months, with options to extend for a further 36 months. Please refer to the invitation to offer documents for the list of purchasing points.
NHS framework agreement to supply aseptically prepared cytotoxic medicines and monoclonal antibodies — East of England, London and South East Coast. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework agreement will commence on 1.4.2020 for a period of 12 months, with options to extend for a further 36 months. Please refer to the invitation to offer documents for the list of purchasing points.
NHS framework agreement to supply aseptically prepared cytotoxic medicines and monoclonal antibodies — East of England, London and South East Coast. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework agreement will commence on 1.7.2020 for a period of 12 months, with options to extend for a further 36 months. Please refer to the invitation to offer documents for the list of purchasing points.
NHS framework agreement for aseptically prepared cytotoxic medicines and monoclonal antibodies — East of England, London and South East Coast. The framework may be used by private contractors and agents working on behalf of the above. The framework will commence on 1.4.2020 for a period of 12 months until 31.3.2021,with options to extend up to a further 36 months. Please refer to the Invitation to offer documents for the list of purchasing points.
NHS framework agreement for aseptically prepared cytotoxic medicines and monoclonal antibodies — East of England, London and South East Coast. The framework may be used by private contractors and agents working on behalf of the above. The framework will commence on 1.7.2020 for a period of 12 months until 30.6.2021,with options to extend up to a further 36 months. Please refer to the Invitation to offer documents for the list of purchasing points.
A corrigendum was published on 25.10.2019 (ref: 2019/S 207-504697) which referred to the original notice (ref: 2019/S 180-437985). The corrigendum advised that this procurement exercise has been paused until further notice and would not close as advised. The purpose of this corrigendum is to advise that this procurement exercise has now resumed and various changes have been made to the original notice. These changes relate to the framework commencement/period end dates; duration of contract including extension options; time limit for receipt of tenders or requests to participate; minimum time frame during which the tenderer must maintain the tender; date/time of conditions for opening tenders; Review Body.